Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV® (Q64123071)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV® |
clinical trial |
Statements
Safety and Efficacy With Twice Daily Brinzolamide 1%/Brimonidine 0.2% (SIMBRINZA®) as an Adjunctive Therapy to Travoprost 0.004%/Timolol 0.5% (DUOTRAV®) (English)
0 references
24 June 2016
0 references
13 July 2018
0 references
173
0 references
18 year
0 references